OrbiMed Capital GP V LLC (CIK 1615374) reported 10 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-04-09). Recent activity: Sell ACET (29,319 shares), Sell ACET (2,400 shares), Sell ACET (32,523 shares), Sell ACET (40,416 shares), Sell PMVP (1.0M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-09 | Adicet Bio, Inc. (ACET) | Insider | Sell | 29,319 | $191,453 |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | Insider | Sell | 2,400 | $15,312 |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | Insider | Sell | 32,523 | $204,570 |
| 2026-04-09 | Adicet Bio, Inc. (ACET) | Insider | Sell | 40,416 | $263,512 |
| 2025-10-27 | PMV Pharmaceuticals, Inc. (PMVP) | Insider | Sell | 1.0M | $1.5M |
| 2025-10-10 | Adicet Bio, Inc. (ACET) | Insider | Buy | 1.5M | $0 |
| 2025-10-10 | Adicet Bio, Inc. (ACET) | Insider | Buy | 3.5M | $0 |
| 2025-09-12 | PMV Pharmaceuticals, Inc. (PMVP) | Insider | Sell | 500,000 | $900,000 |
| 2025-07-01 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 1.4M | $4.9M |
| 2025-07-01 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Sell | 1.2M | $4.9M |
Source: SEC Form 4 filings · as of 2026-04-09